Evolving Landscape of Advanced Melanoma Management

In this opening segment, Dr. Morrison provides a foundational overview of advanced melanoma, including how metastatic disease is currently defined and how treatment outcomes have evolved over the past decade. He discusses the shift in management driven by the introduction of immune checkpoint inhibitors, which have significantly improved survival outcomes compared with historical expectations. The conversation highlights how advances in therapy have led to more durable responses and better disease control for many patients, while also noting that outcomes can vary based on individual clinical factors. Dr. Morrison emphasizes the importance of understanding the current treatment landscape as a framework for evaluating newer approaches in care. This segment sets the clinical context for the discussion, preparing the audience for a deeper exploration of treatment delivery methods and their implications for patient experience in advanced melanoma.